Recurrent serious infections. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Organisms11

Acinetobacter baumannii Staphylococcus aureus Pseudomonas aeruginosa Gram-Negative Bacteria Enterobacteriaceae Staphylococcus Methicillin-Resistant Staphylococcus aureus Klebsiella pneumoniae Gram-Positive Bacteria Streptococcus pneumoniae Bacteria

Diseases26

Infection Opportunistic Infections Bacterial Infections Arthritis, Rheumatoid Skin Diseases, Infectious Enterobacteriaceae Infections Bacteremia Gram-Positive Bacterial Infections Sepsis Pyelonephritis Communicable Diseases Meningitis Osteomyelitis Cross Infection Staphylococcal Infections Streptococcal Infections Endocarditis, Bacterial Pneumonia Pseudomonas Infections Gram-Negative Bacterial Infections Fever Acinetobacter Infections Urinary Tract Infections Pneumonia, Bacterial Neutropenia Acute Disease

Chemicals and Drugs37

Antirheumatic Agents Anti-Bacterial Agents Immunologic Factors Thienamycins Cephradine Methotrexate Cilastatin Minocycline Ceftriaxone Aztreonam Antibodies, Monoclonal, Humanized Abortifacient Agents, Nonsteroidal Antibodies, Monoclonal Moxalactam Colistin Acetamides Oxazolidinones Tumor Necrosis Factor-alpha Cefotaxime Immunoconjugates Aminoglycosides Carbapenems Imipenem Vancomycin Misoprostol Piperacillin Cephalosporins Anti-Infective Agents Antibodies, Monoclonal, Murine-Derived Glucocorticoids Receptors, Tumor Necrosis Factor Immunosuppressive Agents Immunoglobulin G Gentamicins beta-Lactamases Bacterial Proteins DNA, Bacterial

Analytical, Diagnostic and Therapeutic Techniques and Equipment29

Administration, Buccal Clinical Chemistry Tests Drug Therapy, Combination Microbial Sensitivity Tests Treatment Outcome Hematologic Tests Double-Blind Method Patient Care Hospitalization Retrospective Studies Antibiotic Prophylaxis Risk Risk Factors Critical Care Diagnostic Tests, Routine Severity of Illness Index Drug Administration Schedule Prospective Studies Randomized Controlled Trials as Topic Injections, Intravenous Clinical Trials as Topic Follow-Up Studies Incidence Cohort Studies Bacterial Typing Techniques Risk Assessment Polymerase Chain Reaction Proportional Hazards Models Predictive Value of Tests

Phenomena and Processes9

Immunocompromised Host Vancomycin Resistance Drug Resistance, Microbial Drug Resistance, Multiple, Bacterial Drug Resistance, Bacterial Risk Methicillin Resistance Time Factors Dose-Response Relationship, Drug

Disciplines and Occupations1

Information Science3

Incidence Databases, Factual Molecular Sequence Data

Named Groups1

Infant, Newborn

Health Care19

Treatment Outcome Double-Blind Method Patient Care Laboratories Hospitalization Retrospective Studies Risk Risk Factors Critical Care Severity of Illness Index Prospective Studies Randomized Controlled Trials as Topic Clinical Trials as Topic Follow-Up Studies Incidence Cohort Studies Risk Assessment Proportional Hazards Models Predictive Value of Tests

Geographicals3

Belgium Great Britain United States

Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Infection Antirheumatic Agents Opportunistic Infections Bacterial Infections Anti-Bacterial Agents Administration, Buccal Arthritis, Rheumatoid Clinical Chemistry Tests Drug Therapy, Combination Immunologic Factors Skin Diseases, Infectious Enterobacteriaceae Infections Thienamycins Microbial Sensitivity Tests Immunocompromised Host Cephradine Methotrexate Bacteremia Gram-Positive Bacterial Infections Cilastatin Sepsis Pyelonephritis Belgium Communicable Diseases Treatment Outcome Minocycline Ceftriaxone Meningitis Aztreonam Hematologic Tests Antibodies, Monoclonal, Humanized Abortifacient Agents, Nonsteroidal Antibodies, Monoclonal Moxalactam Osteomyelitis Cross Infection Colistin Staphylococcal Infections Acetamides Acinetobacter baumannii Oxazolidinones Tumor Necrosis Factor-alpha Cefotaxime Immunoconjugates Aminoglycosides Double-Blind Method Streptococcal Infections Carbapenems Imipenem Vancomycin Endocarditis, Bacterial Staphylococcus aureus Pneumonia Pseudomonas aeruginosa Infant, Newborn Misoprostol Vancomycin Resistance Pseudomonas Infections Drug Resistance, Microbial Piperacillin Cephalosporins Anti-Infective Agents Pediatrics Gram-Negative Bacterial Infections Fever Patient Care Antibodies, Monoclonal, Murine-Derived Glucocorticoids Acinetobacter Infections Receptors, Tumor Necrosis Factor Drug Resistance, Multiple, Bacterial Gram-Negative Bacteria Enterobacteriaceae Laboratories Immunosuppressive Agents Hospitalization Immunoglobulin G Staphylococcus Urinary Tract Infections Drug Resistance, Bacterial Gentamicins Methicillin-Resistant Staphylococcus aureus Pneumonia, Bacterial Retrospective Studies Antibiotic Prophylaxis Klebsiella pneumoniae Risk Methicillin Resistance Risk Factors Gram-Positive Bacteria beta-Lactamases Neutropenia Critical Care Streptococcus pneumoniae Diagnostic Tests, Routine Acute Disease Great Britain Bacteria Severity of Illness Index Drug Administration Schedule

No FAQ available that match "recurrent serious infections"